Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoblastic Lymphoma (LBL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07623681
What this trial is testing

Single-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

Who this might be right for
CD7+ T-ALL/LBL
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06874946
What this trial is testing

Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL

Who this might be right for
Precursor T-Cell Lymphoblastic Leukemia-LymphomaT - Cell LymphomaPTCL
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02518113
What this trial is testing

LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma
Eli Lilly and Company 36
Early research (Phase 1)Study completedNCT00406757
What this trial is testing

Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

Who this might be right for
Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic
GlaxoSmithKline 13
Large-scale testing (Phase 3)Looking for participantsNCT04043494
What this trial is testing

International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

Who this might be right for
Lymphoblastic Lymphoma, Childhood
University Hospital Muenster 683
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861348
What this trial is testing

Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT

Who this might be right for
Leukemia, Lymphocytic, Acute
First Affiliated Hospital of Zhejiang University 23
Early research (Phase 1)Looking for participantsNCT07280494
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Who this might be right for
CD7+ T-ALL/LBL
Peking University People's Hospital 18
Testing effectiveness (Phase 2)WithdrawnNCT02150928
What this trial is testing

An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
Jazz Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06742463
What this trial is testing

VHAG in Treating R/R T-ALL/LBL

Who this might be right for
Acute T Lymphpblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang University 50
Testing effectiveness (Phase 2)Ended earlyNCT02999633
What this trial is testing

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Who this might be right for
T-cell Type Acute Leukemia-PrecursorT-lymphoblastic Lymphoma/Leukaemia
Sanofi 14
Early research (Phase 1)Looking for participantsNCT06909474
What this trial is testing

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Who this might be right for
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd 15
Early research (Phase 1)Looking for participantsNCT07109518
What this trial is testing

UCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableLooking for participantsNCT07632014
What this trial is testing

CAYA Cancer Prospective Cohort Study

Who this might be right for
CancerPediatric CancerLymphoblastic Lymphoma (LBL)+1 more
Resonance, Inc. 6,000
Not applicableEnrolling By InvitationNCT05509855
What this trial is testing

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma
Allotera Therapeutics 44
Very early researchStudy completedNCT05716113
What this trial is testing

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
NeoplasmsHematologic NeoplasmsNeoplasms by Site+1 more
He Huang 20
Not applicableLooking for participantsNCT07246213
What this trial is testing

CAYA Cancer Retrospective Cohort Study

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic LymphomaYoung Adult Cancer+4 more
Resonance, Inc. 18,000
Testing effectiveness (Phase 2)Looking for participantsNCT07153068
What this trial is testing

SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Who this might be right for
T Lymphoblastic Leukemia/LymphomaAcute Myeloid Leukemia (AML)
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)UnknownNCT05598593
What this trial is testing

Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL

Who this might be right for
Cytarabine+Thiotepa + Fludarabine + BusulfanT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
First Affiliated Hospital of Zhejiang University 70
Early research (Phase 1)UnknownNCT05554575
What this trial is testing

Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL

Who this might be right for
T Cell Lymphoblastic Lymphoma
Bioceltech Therapeutics, Ltd. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07070219
What this trial is testing

CTD402 in T-ALL/LBL Patients

Who this might be right for
Acute Lymphocytic Leukemia RefractoryLymphoma, Lymphoblastic
Imviva Bio 118
Next Page